Course Description:
This webinar will describe the validated analytical methods for testing cannabinoid and terpene content, and the relevant USP General Chapters (e.g., <232>, <561>) and why, and how to get more information to aid in ensuring cannabis quality. The presentation will highlight the complementary nature of the proposed GC <1568> to the FDA guidance on cannabis quality for clinical research.
Who Should Participate:
Clinical trial investigators and researchers, cannabis research material providers and the testing labs that may support these groups.
Access Duration:
Access to this course expires 6 months from the date of registration or until you mark the course ‘Complete’ – whichever occurs first.
Speaker
Nandakumara Sarma, Ph.D.
Director, Dietary Supplement Standards,
Science-DS & Herbal Meds, USP